| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $32.0M | — | +82.2% |
| Cost of Revenue | $32.2M | — | +0.0% |
| Gross Profit | -$15.9M | — | -8.9% |
| R&D Expense | $840K | — | -39.6% |
| SG&A Expense | $4.1M | — | +43.7% |
| Operating Income | -$20.8M | — | -10.6% |
| Pre-tax Income | -$20.6M | — | -16.7% |
| Income Tax | $8K | — | +33.3% |
| Net Income | -$20.6M | — | -16.7% |
| EPS (Basic) | -$0.47 | — | -17.5% |
| EPS (Diluted) | -$0.47 | — | -17.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $22.4M | -56.4% | -77.0% |
| Accounts Receivable | $13.3M | +41.5% | +67.9% |
| Inventory | $31.1M | +46.3% | +16.6% |
| Current Assets | $84.1M | -16.3% | -41.3% |
| Total Assets | $179.0M | -6.9% | -21.4% |
| Current Liabilities | $17.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$20.0M | — | -270.6% |
| Capital Expenditures | $5.4M | — | +34.6% |
| Investing Cash Flow | -$6.3M | — | -54.9% |
| Financing Cash Flow | -$2.6M | — | +12.1% |
| Free Cash Flow | -$25.4M | — | -170.1% |
| -42.5% |
| Total Liabilities | $37.1M | -1.2% | -5.6% |
| Stockholders' Equity | $141.9M | -8.3% | -24.7% |